Take a look at that smirk. It probably won’t be there much any longer.
After hiking the price of Daraprim (a $1 pill taken primarily by AIDS patients) over 5000%, Martin Shkreli – the most hated man in pharmaceuticals – is about to be torpedoed by the maker of generic drugs who now plan on selling the pill for $1 again.
San Diego-based Imprimis Pharmaceuticals Inc., which mixes approved drug ingredients to fill individual patient prescriptions, said Thursday it will supply capsules containing Daraprim’s active ingredients, pyrimethamine and leucovorin, for $99 for a 100-capsule bottle, via its site: www.imprimiscares.com.
The 3 1/2-year-old drug compounding firm also plans to start making inexpensive versions of other generic drugs whose prices have skyrocketed, Chief Executive Mark Baum told The Associated Press.
“We are looking at all of these cases where the sole-source generic companies are jacking the price way up,” Baum said in an interview. “There’ll be many more of these” compounded drugs coming in the near future.